We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Limited Growth Foreseen in US Arthroscopy Market

By LabMedica International staff writers
Posted on 27 Dec 2011
Price competition and the increased use of reprocessed and refurbished devices will limit the growth of the US arthroscopy market. More...
These are the latest findings of the Millennium Research Group (MRG; Toronto, Canada), a global authority on medical technology market intelligence.

While the demand for arthroscopy procedures, including knee, shoulder, small-joint and hip procedures will continue to grow steadily due to the numerous benefits of minimally-invasive surgeries, downward pressures on prices, which include increased reuse and refurbishing as well as reimbursement controls, will limit revenue growth. There will also be a significant downward pressure on the selling price of arthroscopic devices, resulting in a moderate four percent annual growth rate through 2016.

The mature and commoditized arthroscopy market has seen little technical innovation in recent years; as a result, products are relatively undifferentiated and competition is largely on price. Additionally, increasing rates of reprocessing of single-use devices and refurbishing of reusable devices will exert further downward pressure on selling prices. While physicians are wary of using reprocessed products, facilities have a significant incentive to reduce costs.

“The poor economy and changes in health insurance regulations will have a negative effect on the budgets of the ambulatory care centers where the majority of arthroscopy procedures are performed,” said MRG analyst Canny Ho. “Many of these procedures are considered elective and patients aren’t willing to pay the out-of-pocket costs associated with treatment. This factor, in combination with product bundling and the challenge of remaining competitive against reprocessed and refurbished devices, will continue to drive selling prices down in most segments of the market.”

Arthroscopic procedures show faster recovery times and lower complication rates when compared to open surgery and can also be performed on an outpatient basis. Smith & Nephew (London, United Kingdom) has the largest share of the arthroscopy device market, but has strong competition from ConMed Linvatec (Largo, FL, USA), Stryker, and Arthrocare (Austin, TX, USA).

Related Links:
Millennium Research Group
Smith & Nephew
ConMed Linvatec




Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Immunofluorescence Analyzer
IFA System
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.